World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

PREVALENCE OF URINARY TRACT INFECTION AND RISK FACTORS AMONG PATIENTS

Muhammad Fahad Iqbal*, Shafaq Jameel and Aatir Farhan

ABSTRACT

Urinary tract infections are among the most common bacterial infections in humans both in the community and hospital settings, and they occur in all age groups, and usually required urgent treatment. All the patients presenting with history of burning micturition and dysuria were included in this study. A total of 108 patients including male and female of ages between 18 to 60 years were included. There were 58 (53.70%) females and 50 (46.30%) males in the study. The mean age of all the patients was 35.34±2.12 years. The mean time for onset of symptoms was 23.89±3.45 days, with the minimum of 7 days and the maximum of 52 days. The symptoms were of greater duration in female patients than the male patients.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR